Labeler
Camber Pharmaceuticals, Inc. NDC Codes
Camber Pharmaceuticals, Inc. lists 643 finished drug products in the FDA NDC Directory under NDC labeler code 31722.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Buprenorphine and Naloxone, Milnacipran Hydrochloride, Olmesartan medoxomil, amlodipine and hydrochlorothiazide, Eltrombopag, Topiramate, Pomalidomide, Fluphenazine Hydrochloride, mirtazapine, Afatinib, Losartan Potassium And Hydrochlorothiazide, Cisatracurium Besylate, Oxycodone Hydrochloride, spironolactone, Olmesartan medoxomil and hydrochlorothiazide, Sacubitril and valsartan
- Active ingredients
- Hydrochlorothiazide, Olmesartan medoxomil, Buprenorphine hydrochloride, Amlodipine besylate, Eltrombopag olamine, Naloxone hydrochloride, Topiramate, Milnacipran hydrochloride, Pomalidomide, Fluphenazine hydrochloride, Mirtazapine, Afatinib dimaleate
- NDC labeler codes
- 31722
- Strengths (from the 100 most recently listed products)
- Hydrochlorothiazide 12.5 mg/1; Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 25 mg/1; Buprenorphine hydrochloride 2 mg/1; Buprenorphine hydrochloride 8 mg/1; Olmesartan medoxomil 20 mg/1; Amlodipine besylate 5 mg/1; Sugammadex sodium 100 mg/mL; Losartan potassium 100 mg/1; Cisatracurium besylate 2 mg/mL; Amlodipine besylate 10 mg/1; Acetaminophen 325 mg/1; Carbidopa 25 mg/1; Levodopa 100 mg/1; Eltrombopag olamine 12.5 mg/1; Clomiphene citrate 50 mg/1; Glycerol phenylbutyrate 1.1 g/mL; Afatinib dimaleate 20 mg/1; Afatinib dimaleate 30 mg/1; Afatinib dimaleate 40 mg/1
- Dosage forms
- Tablet, Film coated, Tablet, Capsule, Capsule, Extended release, Injection, Solution, Film, Soluble, Injection, Solution, Kit, Suspension, Tablet, Extended release, Powder, For suspension, Liquid, Powder, For solution, Injection, Powder, Lyophilized, For solution, Suppository
- Routes
- Oral, Sublingual, Intravenous, Buccal, Rectal, Subcutaneous, Intramuscular
- Drug classes (FDA established)
- Angiotensin 2 Receptor Blocker, Thiazide Diuretic, Partial Opioid Agonist, Opioid Antagonist, Kinase Inhibitor, Phenothiazine, Opioid Agonist, Calcium Channel Blocker, Dihydropyridine Calcium Channel Blocker, Thrombopoietin Receptor Agonist, Serotonin and Norepinephrine Reuptake Inhibitor, Thalidomide Analog, Nondepolarizing Neuromuscular Blocker, Serotonin Reuptake Inhibitor, Aldosterone Antagonist, Neprilysin Inhibitor, Aromatic Amino Acid, Histamine-1 Receptor Antagonist, Aminoketone, Serotonin-1b and Serotonin-1d Receptor Agonist, Serotonin-4 Receptor Agonist, Chloride Channel Activator, Estrogen Agonist/Antagonist, Nitrogen Binding Agent, Amino Acid, Sigma-1 Agonist, Uncompetitive N-methyl-D-aspartate Receptor Antagonist, Central Nervous System Depressant, Aminosalicylate, Azole Antifungal, Tetracycline-class Drug, Nonsteroidal Anti-inflammatory Drug, Nitrofuran Antibacterial, Hematopoietic Stem Cell Mobilizer, Calculi Dissolution Agent, Osmotic Laxative, Retinoid, Factor Xa Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 184 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Clomiphene Citrate | Clomiphene citrate 50 mg/1 | TabletOral | 31722-541 | 31722-0541-3231722-0541-33 | — |
| Glycerol Phenylbutyrateglycerol phenylbutyrate oral | Glycerol phenylbutyrate 1.1 g/mL | LiquidOral | 31722-605 | 31722-0605-3131722-0605-32 | — |
| Sugammadex | Sugammadex sodium 100 mg/mL | InjectionIntravenous | 31722-254 | 31722-0254-10 | — |
| Sugammadex | Sugammadex sodium 100 mg/mL | Injection, SolutionIntravenous | 31722-255 | 31722-0255-10 | — |
| Afatinib | Afatinib dimaleate 20 mg/1 | Tablet, Film coatedOral | 31722-781 | 31722-0781-30 | — |
| Afatinib | Afatinib dimaleate 30 mg/1 | Tablet, Film coatedOral | 31722-782 | 31722-0782-30 | — |
| Afatinib | Afatinib dimaleate 40 mg/1 | Tablet, Film coatedOral | 31722-783 | 31722-0783-30 | — |
| Diphenhydramine hydrochloride | Diphenhydramine hydrochloride 12.5 mg/5mL | SolutionOral | 31722-600 | 31722-0600-1131722-0600-31 | — |
| Diphenhydramine hydrochloride | Diphenhydramine hydrochloride 25 mg/10mL | SolutionOral | 31722-601 | 31722-0601-31 | — |
| Losartan Potassium And Hydrochlorothiazide | Losartan potassium 50 mg/1; Hydrochlorothiazide 12.5 mg/1 | Tablet, Film coatedOral | 31722-755 | 31722-0755-1031722-0755-3031722-0755-90 | — |
| Losartan Potassium And Hydrochlorothiazide | Losartan potassium 100 mg/1; Hydrochlorothiazide 12.5 mg/1 | Tablet, Film coatedOral | 31722-756 | 31722-0756-1031722-0756-3031722-0756-90 | — |
| Losartan Potassium And Hydrochlorothiazide | Losartan potassium 100 mg/1; Hydrochlorothiazide 25 mg/1 | Tablet, Film coatedOral | 31722-757 | 31722-0757-1031722-0757-3031722-0757-90 | — |
| L-glutamine | Glutamine 5 g/1 | Powder, For solutionOral | 31722-483 | 31722-0483-60 | — |
| Cisatracurium Besylate | Cisatracurium besylate 10 mg/mL | InjectionIntravenous | 31722-312 | 31722-0312-10 | — |
| Cisatracurium Besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | 31722-313 | 31722-0313-10 | — |
| Cisatracurium Besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | 31722-314 | 31722-0314-10 | — |
| Buprenorphine and Naloxone | Buprenorphine hydrochloride 2 mg/1; Naloxone hydrochloride .5 mg/1 | Film, SolubleBuccal, Sublingual | 31722-479 | 31722-0479-30 | — |
| Buprenorphine and Naloxone | Buprenorphine hydrochloride 4 mg/1; Naloxone hydrochloride 1 mg/1 | Film, SolubleBuccal, Sublingual | 31722-480 | 31722-0480-30 | — |
| Buprenorphine and Naloxone | Buprenorphine hydrochloride 8 mg/1; Naloxone hydrochloride 2 mg/1 | Film, SolubleBuccal, Sublingual | 31722-481 | 31722-0481-30 | — |
| Buprenorphine and Naloxone | Buprenorphine hydrochloride 12 mg/1; Naloxone hydrochloride 3 mg/1 | Film, SolubleBuccal, Sublingual | 31722-482 | 31722-0482-30 | — |
| Topiramate | Topiramate 25 mg/1 | Capsule, Extended releaseOral | 31722-547 | 31722-0547-30 | — |
| Topiramate | Topiramate 50 mg/1 | Capsule, Extended releaseOral | 31722-548 | 31722-0548-30 | — |
| Topiramate | Topiramate 100 mg/1 | Capsule, Extended releaseOral | 31722-549 | 31722-0549-30 | — |
| Topiramate | Topiramate 200 mg/1 | Capsule, Extended releaseOral | 31722-550 | 31722-0550-30 | — |
| Milnacipran Hydrochloride | Milnacipran hydrochloride 12.5 mg/1 | Tablet, Film coatedOral | 31722-846 | 31722-0846-3231722-0846-60 | — |
| Milnacipran Hydrochloride | Milnacipran hydrochloride 25 mg/1 | Tablet, Film coatedOral | 31722-847 | 31722-0847-3231722-0847-60 | — |
| Milnacipran Hydrochloride | Milnacipran hydrochloride 50 mg/1 | Tablet, Film coatedOral | 31722-848 | 31722-0848-3231722-0848-60 | — |
| Milnacipran Hydrochloride | Milnacipran hydrochloride 100 mg/1 | Tablet, Film coatedOral | 31722-849 | 31722-0849-3231722-0849-60 | — |
| Milnacipran Hydrochloride | — | Kit | 31722-880 | 31722-0880-31 | — |
| Desogestrel and Ethinyl Estradiol | — | Kit | 31722-540 | 31722-0540-3331722-0540-34 | — |
| Promethazine Hydrochloride And Dextromethorphan Hydrobromide | Promethazine hydrochloride 6.25 mg/5mL; Dextromethorphan hydrobromide 15 mg/5mL | SolutionOral | 31722-692 | 31722-0692-1131722-0692-47 | — |
| Paroxetine Hydrochloride | Paroxetine hydrochloride 10 mg/5mL | SuspensionOral | 31722-578 | 31722-0578-25 | — |
| Pomalidomide | Pomalidomide 1 mg/1 | CapsuleOral | 31722-770 | 31722-0770-0131722-0770-2131722-0770-32 | — |
| Pomalidomide | Pomalidomide 2 mg/1 | CapsuleOral | 31722-771 | 31722-0771-0131722-0771-2131722-0771-32 | — |
| Pomalidomide | Pomalidomide 3 mg/1 | CapsuleOral | 31722-772 | 31722-0772-0131722-0772-2131722-0772-32 | — |
| Pomalidomide | Pomalidomide 4 mg/1 | CapsuleOral | 31722-773 | 31722-0773-0131722-0773-2131722-0773-32 | — |
| Buprenorphine HCl | Buprenorphine hydrochloride 2 mg/1 | TabletSublingual | 31722-870 | 31722-0870-30 | — |
| Buprenorphine HCl | Buprenorphine hydrochloride 8 mg/1 | TabletSublingual | 31722-871 | 31722-0871-30 | — |
| Buprenorphine and Naloxone | Buprenorphine hydrochloride 2 mg/1; Naloxone hydrochloride dihydrate .5 mg/1 | TabletSublingual | 31722-850 | 31722-0850-30 | — |
| Buprenorphine and Naloxone | Buprenorphine hydrochloride 8 mg/1; Naloxone hydrochloride dihydrate 2 mg/1 | TabletSublingual | 31722-851 | 31722-0851-30 | — |
| sodium oxybate | Sodium oxybate .5 g/mL | SolutionOral | 31722-891 | 31722-0891-18 | — |
| Nilotinib | Nilotinib 150 mg/1 | CapsuleOral | 31722-779 | 31722-0779-33 | — |
| Nilotinib | Nilotinib 200 mg/1 | CapsuleOral | 31722-780 | 31722-0780-33 | — |
| Fluphenazine Hydrochloride | Fluphenazine hydrochloride 1 mg/1 | Tablet, Film coatedOral | 31722-384 | 31722-0384-0131722-0384-05 | — |
| Fluphenazine Hydrochloride | Fluphenazine hydrochloride 2.5 mg/1 | Tablet, Film coatedOral | 31722-385 | 31722-0385-0131722-0385-05 | — |
| Fluphenazine Hydrochloride | Fluphenazine hydrochloride 5 mg/1 | Tablet, Film coatedOral | 31722-386 | 31722-0386-0131722-0386-05 | — |
| Fluphenazine Hydrochloride | Fluphenazine hydrochloride 10 mg/1 | Tablet, Film coatedOral | 31722-387 | 31722-0387-0131722-0387-05 | — |
| Oxycodone Hydrochloride | Oxycodone hydrochloride 5 mg/1 | TabletOral | 31722-484 | 31722-0484-0131722-0484-05 | — |
| Oxycodone Hydrochloride | Oxycodone hydrochloride 10 mg/1 | TabletOral | 31722-485 | 31722-0485-0131722-0485-05 | — |
| Oxycodone Hydrochloride | Oxycodone hydrochloride 20 mg/1 | TabletOral | 31722-486 | 31722-0486-0131722-0486-05 | — |
Camber Pharmaceuticals, Inc.: common questions
- What is Camber Pharmaceuticals, Inc.'s NDC labeler code?
- 31722. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Camber Pharmaceuticals, Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.